ClinicalTrials.gg
TerminatedNCT02490813TCMFAUpdated Mar 1, 2023

Pilot Study on Traditional Chinese Medicine and Food Allergy

An interventional study of Treatment - Chinese Herbal Formula - X and Placebo in Allergy to Fish, Allergy to Shrimp and Allergy to Crab, sponsored by Hong Kong Sanatorium & Hospital. Terminated at 1 site in Hong Kong. Open to participants aged 8 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-01.

Sponsored by Hong Kong Sanatorium & Hospital · Not applicable, Interventional, and Treatment

Why this study was terminated
the study has been on hold throughout 3/10/2020-18/2/2023 due to the hospital regulations for COVID-19
Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Randomized
Ages
8 Years and older
Sex
All
01

Study summary

Recently, there has been an increasing interest in using traditional Chinese medicine for food allergy. The Harvard group has successfully demonstrated the Food Allergy Herbal Formula - FAHF2 completely blocked peanut-induced anaphylaxis in a murine model, and currently being studied in human. Therefore, in collaboration with the Institute of Chinese Medicine, CUHK, the investigators have developed a more simplified Chinese herbal formula - X (CHFX), containing four food-grade Chinese herbs, Wu-mei (Fructus Pruni Mume); Ling-zhi (Gonoderma); Huang-bai (Cortex Phellodendron) and Zhi-su (Perilla frutescens).

In the present study, the investigators would like to examine whether there is reduction in allergic symptoms in food challenge after administering the CHFX for 8 weeks. There will be pre- and post- CHFX food challenges and other related tests.

Read the detailed description

The investigators aim to recruit 24 subjects for the present study. Subjects will be randomized into two groups, control group (n=12) and treatment group (n=12). At recruitment all subjects will be required to stop anti-allergic medicines and Chinese medicines as a wash out period for two weeks (week 1 and week 2). They will be required to keep a record of their symptoms and peak flow rates twice daily throughout the entire study. Skin prick test will be performed with a panel of commercially available skin test solutions for cod, shrimp and crab (ALK). Total and specific IgE as well as total and specific IgG4 for fish and shellfish will be measured (by the HKSH laboratory or CUHK laboratory). Graded open cod, shrimp or crab challenge will be performed as described later at HKSH in each patient to determine the baseline tolerance level to fish or shellfish, using freeze-dried cod, shrimp or crab as appropriate.

After determining the baseline tolerance level, subjects in the treatment group will take 2 grams of the CHFX or placebo daily for 8 weeks (week 4 to week 11). The placebo powder consists of food grade medicinal starch blended with coloring agent. After the 8 weeks of treatment, skin prick tests, blood tests as at baseline and oral challenges will be repeated (week 12). During the study subjects will be requested to consume their normal diet but avoiding fish and shellfish, with no consumption of any other Chinese herbal medication. They can take anti-allergic medicines as necessary but will note when medicines are taken in their symptom and peak flow diary.

02

Conditions studied

  • Allergy to Fish
  • Allergy to Shrimp
  • Allergy to Crab

Keywords

  • Fish allergy
  • shrimp allergy
  • crab allergy
  • traditional Chinese medicine
03

In context

Lead sponsor

Hong Kong Sanatorium & Hospital is the lead sponsor of 9 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 8 years or older with a history of allergic reaction to cod, shrimp or crab, manifested by any of the following: urticaria, angioedema, asthma or anaphylaxis, within 60 mins of ingestion.
  • Having a positive skin prick test to the cod, shrimp or crab as defined by a weal diameter 3 mm greater than the diluent control.
  • Having a positive oral challenge with freeze-dried cod, shrimp or crab.
  • Asthma must be under control with a of at least 80% predicted value.
  • Aspirin, anti-histamines/anti-allergic medicines and antidepressants are not permitted for 3 days, one week and two weeks, respectively, before skin testing or oral food challenge.

Exclusion criteria

Exclusion Criteria:

  • Pregnancy.
  • Requiring systemic , beta-blockers and ACE inhibitors.
  • Having poorly controlled asthma, poorly controlled atopic dermatitis prior to study.
  • Inability to discontinue antihistamines or other medication for skin testing and oral challenges.
  • Unable to comply with the study protocol for any reason.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

FEV1

From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
18 participants (actual)

Study arms

  • Placebo comparator
    Control

    This arm will receive the placebo.

    Dietary Supplement: Placebo

  • Experimental
    Treatment - Chinese Herbal Formula - X

    This arm will receive the Chinese Herbal Formula - CHFX as treatment to their existing fish, shrimp or crab allergy.

    Dietary Supplement: Treatment - Chinese Herbal Formula - X

Interventions

  • Dietary supplementTreatment - Chinese Herbal Formula - X

    Wu Mei (Fructus Pruni Mume), Ling Zhi (Gonoderma), Huang Bai (Cortex Phellodendron), and Zhi Su (Perilla frutescens).

  • Dietary supplementPlacebo

    Placebo will be starch with colorings

06

What researchers measure

Primary outcomes

  1. Tolerance to existing allergen

    subjects will be accessed on tolerance to existing allergen via opened oral food challenge

    Time frame: 8 weeks

Secondary outcomes

  1. Skin prick test result

    Skin prick test result to existing allergen

    Time frame: 8 weeks

  2. Blood test - IgE result

    Specific IgE test result to existing allergen

    Time frame: 8 weeks

07

Study locations

1 site
  • Hong Kong Sanatorium & Hospital
    Happy Valley, Hong Kong
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02490813
Lead sponsor
Hong Kong Sanatorium & Hospital
Responsible party
Sponsor
First posted
Jul 7, 2015
Start date
Jun 18, 2015
Primary completion
Feb 18, 2023
Completion
Feb 18, 2023
Last update
Mar 1, 2023

Study contacts

June Chan, Master
principal investigator · Hong Kong Sanatorium & Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion